223 From RNAi screens to molecular function: A systematic pipeline for gene function in mammalian cells F Buchholz, M Theis, D Krastev, M Slabicki, L Ding EJC Supplements 2 (7), 57, 2009 | | 2009 |
A Genome-Scale DNA Repair RNAi Screen Identifies SPG48 as a Novel Gene M Słabicki, M Theis, DB Krastev, S Samsonov, E Mundwiller | | 2010 |
A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia M Słabicki, M Theis, DB Krastev, S Samsonov, E Mundwiller, M Junqueira, ... PLoS biology 8 (6), e1000408, 2010 | 224 | 2010 |
A Genome-Scale DNA Repair RNAi Screen Identifies SPG48 as a Novel Gene Associated with Hereditary Spastic Paraplegia F Buchholz, AK Heninger, I Poser, F Prieur, J Truchetto, C Confavreux, ... | | 2010 |
A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity L Ding, M Paszkowski-Rogacz, A Nitzsche, MM Slabicki, AK Heninger, ... Cell stem cell 4 (5), 403-415, 2009 | 309 | 2009 |
A STUB1 ubiquitin ligase/CHIC2 protein complex negatively regulates the IL-3, IL-5, and GM-CSF cytokine receptor common β chain (CSF2RB) protein stability SHJ Koochaki, M Słabicki, R Lumpkin, C Zou, R Belizaire, ES Fischer, ... Journal of Biological Chemistry 298 (10), 2022 | 4 | 2022 |
A Systematic Investigation of DNA Double Strand Break Repair by a Genome Wide RNAi Screen in Human Cells: Presented by Mickołaj Michał Słabicki M Słabicki | | 2008 |
A Systematic Investigation of DNA Double Strand Break Repair by a Genome-wide RNAi Screen in Human Cells M Słabicki Verlag nicht ermittelbar, 2008 | | 2008 |
A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly DB Krastev, M Slabicki, M Paszkowski-Rogacz, NC Hubner, M Junqueira, ... Nature cell biology 13 (7), 809-818, 2011 | 90 | 2011 |
ANALYSIS OF MECHANISMS OF MALIGNANT TRANSFORMATION IN TP53 WILD-TYPE BURKITT'S LYMPHOMA BY INTEGRATION OF MOLECULAR AND FUNCTIONAL GENOMICS DATA J Huellein, M Slabicki, M Rosolowski, R Scholtysik, A Jethwa, M Lukas, ... Ferrata Storti Foundation, 2015 | | 2015 |
Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: repurposing clinically available drugs for COVID‐19 therapy RM Boytz, M Słabicki, S Ramaswamy, JJ Patten, C Zou, C Meng, BL Hurst, ... Journal of medical virology 95 (1), e28157, 2023 | 18 | 2023 |
Application of Shotgun Proteomics for Discovery-Driven Protein–Protein Interaction L Goto-Silva, Z Maliga, M Slabicki, JR Murillo, M Junqueira Shotgun Proteomics: Methods and Protocols, 265-278, 2014 | 4 | 2014 |
Author Correction: LAMP-Seq enables sensitive, multiplexed COVID-19 diagnostics using molecular barcoding KU Ludwig, RM Schmithausen, D Li, ML Jacobs, R Hollstein, ... Nature Biotechnology 40 (8), 1295-1295, 2022 | | 2022 |
BTBBCL6 dimers as building blocks for reversible drug-induced protein oligomerization L Nitsch, P Jensen, H Yoon, J Koeppel, SSR Burman, ES Fischer, ... Cell Reports Methods 2 (4), 2022 | 7 | 2022 |
Chemical Specification of E3 Ubiquitin Ligase Engagement by Cysteine-Reactive Chemistry RC Sarott, I You, YD Li, ST Toenjes, KA Donovan, P Seo, M Ordonez, ... Journal of the American Chemical Society 145 (40), 21937-21944, 2023 | 10 | 2023 |
Comparative profiling identifies C13orf3 as a component of the Ska complex required for mammalian cell division M Theis, M Slabicki, M Junqueira, M Paszkowski‐Rogacz, J Sontheimer, ... The EMBO Journal 28 (10), 1453-1465, 2009 | 126 | 2009 |
DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas K Schramm, M Iskar, B Statz, N Jäger, D Haag, M Słabicki, SM Pfister, ... Neuro-oncology 21 (7), 867-877, 2019 | 31 | 2019 |
Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN QL Sievers, G Petzold, RD Bunker, A Renneville, M Słabicki, BJ Liddicoat, ... Science 362 (6414), eaat0572, 2018 | 378 | 2018 |
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells RS Sellar, AS Sperling, M Słabicki, JA Gasser, ME McConkey, ... The Journal of Clinical Investigation 132 (16), 2022 | 21 | 2022 |
Design principles for cyclin K molecular glue degraders Z Kozicka, DJ Suchyta, V Focht, G Kempf, G Petzold, M Jentzsch, C Zou, ... Nature Chemical Biology 20 (1), 93-102, 2024 | 14 | 2024 |